Skip to main content
Top

Cancer Chemotherapy and Pharmacology

Issue 3/2001

Content (15 Articles)

Original Article

Pharmacokinetics of deguelin, a cancer chemopreventive agent in rats

George O. Udeani, Guo-Min Zhao, Young Geun Shin, Jerome W. Kosmeder II, Christopher W.W. Beecher, A. Douglas Kinghorn, Robert M. Moriarty, Richard C. Moon, John M. Pezzuto

Letter to the Editor

UFT-induced haemolytic anaemia

Amado J. Zurita Saavedra, Matilde Navarro Garcia, Ignacio Español, Adela Fernández Ortega

Original Article

Effects of PR-350, a newly developed radiosensitizer, on dihydropyrimidine dehydrogenase activity and 5-fluorouracil pharmacokinetics

M. Watanabe, T. Tateishi, N. Takezawa, M. Tanaka, T. Kumai, S. Nakaya, S. Kobayashi

Clinical Trial Report

Typhlitis (neutropenic enterocolitis) after a single dose of vinorelbine

Eros Ferrazzí, Silvia Toso, Miriam Zanotti, Giuseppina Giuliano

Original Article

Cyclophosphamide metabolism in children following a 1-h and a 24-h infusion

Steven M. Yule, Lisa Price, Mike Cole, Andrew D.J. Pearson, Alan V. Boddy

Original Article

Bisimidazoacridones induce a potent cytostatic effect in colon tumor cells that sensitizes them to killing by UCN-01

Wieslaw M. Cholody, Teresa Kosakowska-Cholody, Christopher J. Michejda

Original Article

Development, characterization and therapy of a disseminated model of childhood neuroblastoma in SCID mice

Joyce Thompson, Sylvie M. Guichard, Pamela J. Cheshire, Lois B. Richmond, Catherine A. Poquette, Susan T. Ragsdale, Bruce Webber, Robert Lorsbach, Mary K. Danks, Peter J. Houghton

Original Article

Cytocidal effect and DNA damage of nedaplatin: a mathematical model and analysis of experimental data

Yasunari Miyagi, Kunihiro Kawanishi, Yuji Miyagi, Shinako Yamada, Junko Yamamoto, Junichi Kodama, Atsushi Hongo, Mitsuo Yoshinouchi, Takafumi Kudo

Erratum

Bioavailability and phase II study of oral UFT plus leucovorin in patients with relapsed or refractory colorectal cancer

Neal J. Meropol, Daryl S. Sonnichsen, Martin J. Birkhofer, Irene Ferreira, Diane Noel

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine